[PDF] Top 20 Formulation and in vitro evaluation of floating capsules of Loratadine
Has 10000 "Formulation and in vitro evaluation of floating capsules of Loratadine" found on our website. Below are the top 20 most common "Formulation and in vitro evaluation of floating capsules of Loratadine".
Formulation and in vitro evaluation of floating capsules of Loratadine
... The hydrocolloids selected were Hydroxypropylmethylcellulose (HPMC K4M) and Carbopol 934. In addition to these hydrocolloids, Polyvinylpyrrolidone (PVP) was used as a binder. The drug and polymers were taken in a ratio ... See full document
8
FORMULATION AND IN VITRO EVALUATION OF RAPIDLY DISINTEGRATING TABLETS OF LORATADINE
... In Vitro Dissolution Studies: In- Vitro dissolution study was performed by using USP type II Apparatus (Paddle type) [Electro lab (ETC-11L) Tablet Dissolution Tester] at 50 ... See full document
7
Formulation and In Vitro Evaluation of Floating Microspheres of Glipizide
... Optimized formulation F8 was chosen for stability studies based on their percentage yield, percentage drug entrapment efficiency and in-vitro drug release ...the Floating microspheres which were ... See full document
10
Formulation and In Vitro Evaluation of Mexiletine Hydrochloride Timed Release Capsules
... in vitro AAP release profiles but different core erosion ratios were administered to four fasted ...a formulation with a large core erosion ratio can significantly increase in vivo drug release from ... See full document
111
FORMULATION AND IN VITRO EVALUATION OF GASTRO RETENTIVE NON EFFERVESCENT TABLETS OF BALOFLOXACIN
... In-vitro dissolution studies : The release rate of Balofloxacin from floating tablet was determined using the United States Pharmacopoeia (USP) dissolution testing apparatus II. The dissolution test was ... See full document
9
Formulation and evaluation of floating drug delivery system of famotidine
... the formulation CF4 showed no significant changes in the drug content, Floating behavior and in vitro drug release characteristics of the bead ...entrapped floating alginate beads containing ... See full document
7
FORMULATION AND IN VITRO EVALUATION OF FLOATING TABLETS OF TELMISARTAN
... The release rate of floating tablets of Telmisartan was determined using USP Dissolution Testing Apparatus II (Paddle type). The dissolution test was performed using 900 ml of 0.1N HCl, at 37 ± 0.5°C and speed of ... See full document
15
Formulation and evaluation of bilayered floating tablets of cefuroxime axetil
... Cefuroxime is a broad-spectrum/ beta lactamase stable, second generation antibiotic with proven record of efficacy and safety in the parenteral management of various infection including urinary tract infections [1]. ... See full document
10
FORMULATION AND EVALUATION OF FLOATING DRUG DELIVERY SYSTEM OF PENTOXIFYLLINE
... In vitro release studies: The drug release rate from floating microspheres was carried out using the USP dissolution paddle assembly (Model DT-06, Erweka, ...of floating microspheres equivalent to ... See full document
10
FORMULATION AND IN VITRO EVALUATION OF MEXILETINE HYDROCHLORIDE TIMED RELEASE CAPSULES
... Timed-release capsules of Mexiletine HC1 were successfully prepared using Lactose, HPMC E15 and Eudragit L 100 by wet granulation ...timed-release capsules were evaluated for pharmacopoeial and ... See full document
13
FORMULATION AND IN VITRO EVALUATION OF ALFUZOSIN HCL FLOATING TABLET
... optimized floating tablet of Alfuzosin ...release floating tablet of Alfuzosin HCl that deliver drug for longer time, reduce dosage frequency & better patient ...HCl floating tablet using Central ... See full document
21
FORMULATION AND IN-VITRO EVALUATION OF TRAMADOL HYDROCHLORIDE FLOATING TABLETS
... The floating lag time of all the dosage forms made of HPMC K100M and Carbopol were found to be satisfactory and were <1 min because HPMC is a hydrophilic polymer and that it swells fast when it comes in contact ... See full document
7
FORMULATION, OPTIMIZATION AND IN VITRO EVALUATION OF FLOATING TABLET OF MISOPROSTOL
... The floating tablet was optimized with respect to different ...the floating layer be optimized carefully so as to control the release and other attributes as shown in table - ... See full document
11
FORMULATION DEVELOPMENT AND IN VIVO RADIOGRAPHIC STUDIES OF DILTIAZEM HYDROCHLORIDE LOADED FLOATING CAPSULES PREPARED BY MODIFIED PULSINCAP TECHNOLOGY
... e) In-vitro Drug Release Studies: The in-vitro drug release study was performed for all the capsules using USP Type - II dissolution apparatus under the following conditions. The medium used was 900 ... See full document
15
FORMULATION AND IN VITRO EVALUATION OF TIZANIDINE HCL FLOATING TABLET
... as a dependent variables. Tablets were prepared by direct compression method & evaluated for pre-compression and post-compression parameters. Dissolution data were fitted to various models to ascertain kinetic of ... See full document
21
Formulation and In vitro Evaluation of Gastroretentive Floating Tablets of Macrolide Antibiotic Based on Effervescent Technology Using Clarithromycin as a model drug
... Uniform thickness of the tablets throughout the batches ensures good tablet strength and shape and is also important with respect to packaging and handling. The thickness of the tablets should be restricted within 5% or ... See full document
8
FORMULATION AND EVALUATION OF FLOATING CAPSULES OF PROPRANOLOL HCl USING MODIFIED PULSINCAP TECHNIQUE
... develop floating capsules of propranolol HCl using PEO WSR ...The formulation mixture was hand filled into the hardened body (formaldehyde exposed) and covered with unhardened ...optimized ... See full document
8
Formulation and evaluation of gastro retentive floating tablets of Loratadine
... regard, Loratadine gastroretentive floating tablets were prepared by using effervescent and Non Effervescent floating technique using polymers such as Ethyl cellulose, Karaya gum and HPMC K4 M as ... See full document
6
FORMULATION AND EVALUATION OF SUSTAINED RELEASE FLOATING TABLETS OF LORATADINE
... Thus, formulation F10 containing a combination of sodium bicarbonate (30mg) and calcium carbonate (30mg) with HPMC K15M (120mg) and sodium alginate (60mg) was found to achieve optimum in-vitro buoyancy and ... See full document
11
FORMULATION DESIGN AND EVALUATION OF NON EFFERVACENT FLOATING TABLETS OF GLICLAZIDEMangulal KethavathDOWNLOAD/VIEW
... or capsules, will result in dissolution of the drug in the gastric ...from floating dosage forms if it remains in the solution form even at the alkaline pH of the ... See full document
8
Related subjects